A novel series of anthracenyl-isoxazole amide (AIM) antitumor agents containing N-heterocycles in the 10 position (N-het) were synthesized using palladium cross-coupling. The unique steric environment of the N-het-AIMs required individual optimization in each case. Lanthanide mediated double activation was used to couple the dimethylamino pyrrole moiety, required for antitumor action. Robust antitumor activity was observed against breast and brain cancer cell lines. The compounds were docked with the c-myc oncogene promoter sequence, which adopts a G4 quadruplex DNA conformation, and represents the working hypothesis for biological action. The N-het-AIMs have useful fluorescence properties, allowing for observation of their distribution within tumor cells.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7933047PMC
http://dx.doi.org/10.1016/j.bmc.2020.115781DOI Listing

Publication Analysis

Top Keywords

breast brain
8
brain cancer
8
cancer cell
8
cell lines
8
fluorescence properties
8
10-n-heterocylic aryl-isoxazole-amides
4
aryl-isoxazole-amides aims
4
aims robust
4
robust anti-tumor
4
anti-tumor activity
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!